Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	CYLC2 MYOM1 KRT19 ACTL7B SPTBN4 PLEC DMD AGRN	1.44e-05	130	168	8	GO:0005200
GeneOntologyMolecularFunction	dystroglycan binding	PLEC DMD AGRN	1.22e-04	12	168	3	GO:0002162
GeneOntologyCellularComponent	costamere	KRT19 CMYA5 PLEC DMD AHNAK2	7.67e-07	22	169	5	GO:0043034
GeneOntologyCellularComponent	contractile muscle fiber	CALD1 MYOM1 IDO1 KRT19 CMYA5 PGM1 PLEC DMD ASB2 AHNAK2	1.30e-04	290	169	10	GO:0043292
GeneOntologyCellularComponent	contractile actin filament bundle	MYLK CALD1 SEPTIN9 MICALL2 ASB2 FSCN1	2.35e-04	107	169	6	GO:0097517
GeneOntologyCellularComponent	stress fiber	MYLK CALD1 SEPTIN9 MICALL2 ASB2 FSCN1	2.35e-04	107	169	6	GO:0001725
GeneOntologyCellularComponent	actin cytoskeleton	MYLK CALD1 KRT19 SEPTIN9 ANKRD26 SPECC1L ACTL7B SPTBN4 NPFFR2 MICALL2 MACF1 ASB2 FSCN1 HSPB7	2.54e-04	576	169	14	GO:0015629
GeneOntologyCellularComponent	actomyosin	MYLK CALD1 SEPTIN9 MICALL2 ASB2 FSCN1	3.81e-04	117	169	6	GO:0042641
GeneOntologyCellularComponent	myofibril	CALD1 MYOM1 KRT19 CMYA5 PGM1 PLEC DMD ASB2 AHNAK2	3.93e-04	273	169	9	GO:0030016
GeneOntologyCellularComponent	actin filament bundle	MYLK CALD1 SEPTIN9 MICALL2 ASB2 FSCN1	3.99e-04	118	169	6	GO:0032432
GeneOntologyCellularComponent	supramolecular fiber	COL6A3 CALD1 MYOM1 IDO1 KRT19 SEPTIN9 NCKIPSD SPECC1L CMYA5 PGM1 FAM83H SPTBN4 TRIM55 MACF1 PLEC DMD ASB2 GOLGA8A AHNAK2 PCNT KIF1C	5.62e-04	1179	169	21	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	COL6A3 CALD1 MYOM1 IDO1 KRT19 SEPTIN9 NCKIPSD SPECC1L CMYA5 PGM1 FAM83H SPTBN4 TRIM55 MACF1 PLEC DMD ASB2 GOLGA8A AHNAK2 PCNT KIF1C	6.13e-04	1187	169	21	GO:0099081
GeneOntologyCellularComponent	phagophore assembly site membrane	ATG2B ATG14 RB1CC1	7.14e-04	22	169	3	GO:0034045
GeneOntologyCellularComponent	sarcolemma	COL6A3 KRT19 PLEC DMD ATP1A3 AGRN AHNAK2	9.17e-04	190	169	7	GO:0042383
GeneOntologyCellularComponent	sarcomere	MYOM1 KRT19 CMYA5 PGM1 PLEC DMD ASB2 AHNAK2	9.75e-04	249	169	8	GO:0030017
GeneOntologyCellularComponent	intermediate filament cytoskeleton	KRT19 NCKIPSD FAM83H PJA2 MTRR MACF1 PLEC DMD	1.38e-03	263	169	8	GO:0045111
GeneOntologyCellularComponent	Z disc	KRT19 PGM1 PLEC DMD ASB2 AHNAK2	1.45e-03	151	169	6	GO:0030018
Domain	ACTININ_2	SPTBN4 CLMN MACF1 PLEC DMD	1.54e-06	23	166	5	PS00020
Domain	ACTININ_1	SPTBN4 CLMN MACF1 PLEC DMD	1.54e-06	23	166	5	PS00019
Domain	Actinin_actin-bd_CS	SPTBN4 CLMN MACF1 PLEC DMD	1.54e-06	23	166	5	IPR001589
Domain	CH	SPECC1L SPTBN4 MICALL2 CLMN MACF1 PLEC DMD	1.74e-06	65	166	7	SM00033
Domain	CH	SPECC1L SPTBN4 MICALL2 CLMN MACF1 PLEC DMD	2.89e-06	70	166	7	PF00307
Domain	-	SPECC1L SPTBN4 MICALL2 CLMN MACF1 PLEC DMD	3.18e-06	71	166	7	1.10.418.10
Domain	CH	SPECC1L SPTBN4 MICALL2 CLMN MACF1 PLEC DMD	3.84e-06	73	166	7	PS50021
Domain	CH-domain	SPECC1L SPTBN4 MICALL2 CLMN MACF1 PLEC DMD	4.61e-06	75	166	7	IPR001715
Domain	FN3	COL6A3 MYLK MYOM1 NRCAM TSPOAP1 CMYA5 DSCAML1 CNTN5 TNXB EPHA10	6.24e-06	185	166	10	SM00060
Domain	FN3	COL6A3 MYLK MYOM1 NRCAM TSPOAP1 CMYA5 DSCAML1 CNTN5 TNXB EPHA10	1.18e-05	199	166	10	PS50853
Domain	fn3	MYLK MYOM1 NRCAM TSPOAP1 CMYA5 DSCAML1 CNTN5 TNXB EPHA10	1.47e-05	162	166	9	PF00041
Domain	FN3_dom	COL6A3 MYLK MYOM1 NRCAM TSPOAP1 CMYA5 DSCAML1 CNTN5 TNXB EPHA10	1.81e-05	209	166	10	IPR003961
Domain	SMARCC_C	SMARCC1 SMARCC2	7.85e-05	2	166	2	IPR032451
Domain	SMARCC_N	SMARCC1 SMARCC2	7.85e-05	2	166	2	IPR032450
Domain	SWIRM-assoc	SMARCC1 SMARCC2	7.85e-05	2	166	2	IPR032448
Domain	SWIRM-assoc_2	SMARCC1 SMARCC2	7.85e-05	2	166	2	PF16496
Domain	SWIRM-assoc_1	SMARCC1 SMARCC2	7.85e-05	2	166	2	PF16495
Domain	SWIRM-assoc_3	SMARCC1 SMARCC2	7.85e-05	2	166	2	PF16498
Domain	Znf_U1	RBM20 ZFHX4 SCAPER ZNF638	1.20e-04	29	166	4	IPR003604
Domain	ZnF_U1	RBM20 ZFHX4 SCAPER ZNF638	1.20e-04	29	166	4	SM00451
Domain	Spectrin_repeat	SPTBN4 MACF1 PLEC DMD	1.20e-04	29	166	4	IPR002017
Domain	SPEC	SPTBN4 MACF1 PLEC DMD	1.78e-04	32	166	4	SM00150
Domain	Spectrin/alpha-actinin	SPTBN4 MACF1 PLEC DMD	1.78e-04	32	166	4	IPR018159
Domain	Chromo/shadow_dom	ARID4B SMARCC1 SMARCC2 CDYL	2.01e-04	33	166	4	IPR000953
Domain	CHROMO	ARID4B SMARCC1 SMARCC2 CDYL	2.01e-04	33	166	4	SM00298
Domain	DUF3496	ANKRD26 CCDC144A	2.34e-04	3	166	2	IPR021885
Domain	DUF3496	ANKRD26 CCDC144A	2.34e-04	3	166	2	PF12001
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2	4.66e-04	4	166	2	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2	4.66e-04	4	166	2	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2	4.66e-04	4	166	2	IPR032754
Domain	LRRC37	LRRC37A3 LRRC37A2	4.66e-04	4	166	2	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2	4.66e-04	4	166	2	IPR015753
Domain	-	CUX2 GON4L NKX1-2 LHX2 ZFHX4 HOXD11 SMARCC1 SMARCC2 PAX4	9.89e-04	283	166	9	1.10.10.60
Domain	Spectrin	SPTBN4 MACF1 DMD	1.07e-03	23	166	3	PF00435
Domain	-	MACF1 PLEC	1.15e-03	6	166	2	3.90.1290.10
Domain	SWIRM	SMARCC1 SMARCC2	1.15e-03	6	166	2	PS50934
Domain	SWIRM	SMARCC1 SMARCC2	1.15e-03	6	166	2	PF04433
Domain	SWIRM	SMARCC1 SMARCC2	1.15e-03	6	166	2	IPR007526
Domain	P-type_ATPase_IIC	ATP1A3 ATP1A4	1.15e-03	6	166	2	IPR005775
Domain	Plectin	MACF1 PLEC	1.60e-03	7	166	2	PF00681
Domain	Plectin_repeat	MACF1 PLEC	1.60e-03	7	166	2	IPR001101
Domain	PLEC	MACF1 PLEC	1.60e-03	7	166	2	SM00250
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CYLC2 RPGRIP1 CUX2 PHACTR2 MYLK CALD1 ATRX KRT19 RSL1D1 ANKRD26 ANKRD30B TKTL1 RRBP1 RPS6KC1 SPTBN4 BPTF TRAP1 C2CD3 PHF20L1 FAM186A SCN9A XRN1 SAFB2 SMARCC1 PALM SMARCC2 MACF1 PLEC DMD ATP1A3 ATP1A4 ZNF292 PCNT	1.95e-13	1442	173	33	35575683
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	CALD1 TCOF1 AIMP1 SEPTIN9 SRGAP2 RB1CC1 RRBP1 PGM1 BPTF USP5 ZNF638 MACF1 PLEC FSCN1 AHNAK2 PCNT	4.31e-11	360	173	16	33111431
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	EXO5 ARID4B ATRX TCOF1 RSL1D1 SEPTIN9 RRBP1 GPRIN1 BPTF SCAF1 ZNF335 SAFB2 ZNF638 SMARCC1 SMARCC2 OXSR1 PLEC DNMBP MN1 SYMPK HDLBP	3.50e-10	774	173	21	15302935
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CALD1 RSL1D1 SEPTIN9 ANKRD26 SRGAP2 SPECC1L RRBP1 TRAP1 RBM19 XRN1 SMARCC1 MTRR MACF1 OXSR1 PLEC DNMBP GEN1 AHNAK2 ZNF292 HDLBP	6.96e-10	724	173	20	36232890
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PHACTR2 KRT19 MAP3K14 NCKIPSD USP43 ANKRD26 SRGAP2 DENND4C FAM83H LPIN3 PJA2 C2CD3 CLMN XRN1 ANKRD11 MACF1 PLEC DNMBP GEN1 AHNAK2 KIF1C	2.33e-09	861	173	21	36931259
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	PHACTR2 CALD1 RSL1D1 SEPTIN9 USP43 SRGAP2 RB1CC1 GPRIN1 DENND4C FAM83H CLMN XRN1 MACF1 PLEC FSCN1 USP15 HDLBP	4.05e-09	565	173	17	25468996
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	BCL9L SYN3 NRCAM AIMP1 TSPOAP1 SEPTIN9 ATG2B RTN3 RRBP1 GPRIN1 BIRC6 RPS6KC1 PJA2 TRAP1 AMER2 CELSR2 XRN1 PALM SMARCC2 MACF1 PLEC USP15 HDLBP	1.33e-08	1139	173	23	36417873
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FRAS1 SRGAP2 BIRC6 CDC14B FAM83H FANCA LPIN3 ZGPAT SCAF1 VAC14 C2CD3 CELSR2 RBM19 ZNF335 ANKRD11 PALM PLEC DNMBP AGRN AHNAK2 PCNT SYMPK	3.62e-08	1105	173	22	35748872
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CALD1 SYN3 NRCAM WDR7 KRT19 SEPTIN9 NCKIPSD RTN3 SRGAP2 SPECC1L RRBP1 PGM1 SPTBN4 USP5 CLMN SCAPER XRN1 PALM SMARCC2 MACF1 PLEC DMD ATP1A3 FSCN1 HDLBP	4.98e-08	1431	173	25	37142655
Pubmed	Tagging genes with cassette-exchange sites.	WDR7 SEPTIN9 BIRC6 BPTF USP5 SAFB2 SMARCC1 MACF1 OXSR1 PLEC FSCN1 ZNF292	1.33e-07	335	173	12	15741177
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	COL6A3 MYOM1 RSL1D1 ANKRD26 GON4L BCL3 CMYA5 BIRC6 PGM1 AKTIP CLMN TRIM55 MACF1 PLEC	2.24e-07	497	173	14	23414517
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	CALD1 ATRX TCOF1 RSL1D1 SEPTIN9 ATG2B ANKRD26 SRGAP2 RRBP1 GPRIN1 TRAP1 CLMN XRN1 SAFB2 ZNF638 MACF1 AHNAK2 PCNT HDLBP	2.39e-07	934	173	19	33916271
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	RSL1D1 GON4L LPIN3 FAM186A ZNF335 SMARCC1 SMARCC2 MACF1 PLEC DMD	3.06e-07	234	173	10	36243803
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	CDC14C COL6A3 FOXN2 SRGAP2 RB1CC1 BIRC6 CDC14B BPTF ZNF335 SAFB2 FGD1 PLEC	3.15e-07	363	173	12	14691545
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	TCOF1 AIMP1 RSL1D1 SEPTIN9 TIMM23 SRGAP2 RRBP1 PPWD1 BIRC6 TOE1 ZGPAT USP5 RBM19 ZNF638 SMARCC1 SMARCC2 MACF1 PLEC FSCN1 ZNHIT2 AHNAK2 KIF1C HDLBP	6.33e-07	1415	173	23	28515276
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	KRT19 TOPAZ1 SEPTIN9 RNF213 BCL3 ZNF831 GPRIN1 FAM186B BIRC6 DSCAML1 PGM1 RPS6KC1 FANCA SCAF1 LONRF2 SYMPK	9.54e-07	736	173	16	29676528
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	ATRX AIMP1 RNF213 BPTF USP5 SAFB2 ZNF638 PLEC AHNAK2 SYMPK HDLBP	9.69e-07	332	173	11	32786267
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	BCL9L FRAS1 RTEL1 CDH23 ACTL7B MACF1 PLEC AGRN	1.02e-06	152	173	8	34299191
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRAS1 NRCAM WDR7 TSPOAP1 SEPTIN9 GON4L SLC39A10 SPATA2 PJA2 MACF1 USP15 PCNT	1.05e-06	407	173	12	12693553
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TCOF1 RSL1D1 BIRC6 BPTF USP5 XRN1 ZNF638 SMARCC1 SMARCC2 MACF1 PLEC FSCN1 PCNT SYMPK HDLBP	1.08e-06	653	173	15	22586326
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	TCOF1 SEPTIN9 RRBP1 BPTF ZNF638 SMARCC1 SMARCC2 PLEC ATP1A4 HDLBP	1.16e-06	271	173	10	32433965
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CCHCR1 CALD1 KRT19 SEPTIN9 ANKRD26 SPATA2 FAM83H PJA2 AKTIP C2CD3 XRN1 PLEC DNMBP USP15 AGRN PCNT KIF1C	1.41e-06	853	173	17	28718761
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	CALD1 SEPTIN9 ATG2B DENND4C XRN1 DNMBP USP15 AHNAK2 HDLBP	1.49e-06	216	173	9	31519766
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CYP4V2 CALD1 ATRX RTEL1 AIMP1 SEPTIN9 SREBF2 RTN3 RNF213 SRGAP2 RRBP1 ZP3 CDC14B SPTBN4 BPTF CLMN ANKRD11 ZNF638 MACF1 OXSR1 GPT2 USP15 PCNT	1.50e-06	1489	173	23	28611215
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TCOF1 WDR7 KRT19 RSL1D1 ANKRD26 MUC16 RNF213 SPECC1L SLC39A10 SPATA2 GPRIN1 BIRC6 RBM19 XRN1 ZNF638 FAM135A	1.92e-06	777	173	16	35844135
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ZNF787 TCOF1 WDR7 NOL12 TOE1 BPTF LHX2 SAFB2 ZNF638 SMARCC1 SMARCC2 MACF1 MPND PLEC AGRN TNXB PIK3R5 ZNF292 SYMPK	2.13e-06	1082	173	19	38697112
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	BCL9L MYOM1 RSL1D1 CDH23 GRM6 SPTBN4 SCAF1 VAC14 ZFHX4 RBM19 MACF1	2.18e-06	361	173	11	26167880
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	SYN3 ATRX RTN3 GPRIN1 AMER2 CLMN SAFB2 SMARCC2 MACF1	2.59e-06	231	173	9	16452087
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CALD1 TCOF1 RSL1D1 SEPTIN9 SPECC1L RB1CC1 RRBP1 FAM83H BPTF SCAF1 TRAP1 SAFB2 ZNF638 SMARCC2 MACF1 PLEC PCNT HDLBP	3.95e-06	1024	173	18	24711643
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RSL1D1 SEPTIN9 RRBP1 BIRC6 TOE1 FAM83H ZGPAT ALKBH1 USP5 RBM19 XRN1 SAFB2 ZNF638 SMARCC1 SMARCC2 MACF1 PLEC FSCN1 AGRN AHNAK2 HDLBP	4.15e-06	1353	173	21	29467282
Pubmed	Intrinsically Disordered Protein TEX264 Mediates ER-phagy.	TCOF1 RTN3 RB1CC1 SAFB2 ZNF638 SMARCC1 SMARCC2	4.43e-06	131	173	7	31006538
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	BCL9L ATRX RB1CC1 ZNF831 BIRC6 TOE1 ZGPAT BPTF ZNF638 SMARCC1 SMARCC2 FSCN1	4.51e-06	469	173	12	27634302
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	NUDT19 FRAS1 ATRX TCOF1 RSL1D1 ANKRD26 RTN3 VARS2 SLC39A10 RB1CC1 RRBP1 GPRIN1 PJA2 CLMN ANKRD11 PALM MACF1 FSCN1 ZNHIT2 FAM135A PCNT HDLBP	5.16e-06	1487	173	22	33957083
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	TCOF1 ATG2B RRBP1 DENND4C XRN1 PLEC USP15 AHNAK2 HDLBP	5.98e-06	256	173	9	33397691
Pubmed	Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice.	COL6A3 FRAS1 AGRN	6.65e-06	8	173	3	12766770
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CCHCR1 ATRX RSL1D1 SREBF2 SRGAP2 SLC39A10 PGM1 RPS6KC1 CLMN SAFB2 ZNF638 SMARCC1 MACF1 PLEC GEN1 AGRN FAM135A PCNT	8.59e-06	1084	173	18	11544199
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	WDR7 ATG2B SREBF2 RTN3 SLC39A10 RRBP1 GPRIN1 TMEM38B DENND4C RPS6KC1 VAC14 FAM135A	9.30e-06	504	173	12	34432599
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	ARID4B GON4L BPTF PHF20L1 SMARCC1 SMARCC2 CDYL	1.08e-05	150	173	7	28242625
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	CCHCR1 SPATA2 FAM83H PJA2 C2CD3 PCNT	1.19e-05	101	173	6	24613305
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	SPECC1L TOE1 ZGPAT USP5 TRAP1 SAFB2 ZNF638 SMARCC1 SMARCC2 OXSR1 PLEC GOLGA8A HDLBP PSD4	1.22e-05	701	173	14	30196744
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CUX2 RTEL1 RRBP1 BIRC6 DSCAML1 MACF1 USP15 PCNT	1.83e-05	225	173	8	12168954
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	NRCAM ATRX TOPAZ1 SEPTIN9 SREBF2 BIRC6 ANKRD11	2.25e-05	168	173	7	30631154
Pubmed	Sensory Experience Modulates Atrx-mediated Neuronal Integrity in the Mouse Retina.	ATRX GRM6	2.46e-05	2	173	2	33197500
Pubmed	Agrin-signaling is necessary for the integration of newly generated neurons in the adult olfactory bulb.	ATP1A3 AGRN	2.46e-05	2	173	2	22423096
Pubmed	Overexpression of CDC14B causes mitotic arrest and inhibits zygotic genome activation in mouse preimplantation embryos.	CDC14C CDC14B	2.46e-05	2	173	2	19923902
Pubmed	The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway.	CDC14C CDC14B	2.46e-05	2	173	2	21502810
Pubmed	The Swi3 protein plays a unique role in regulating respiration in eukaryotes.	SMARCC1 SMARCC2	2.46e-05	2	173	2	27190130
Pubmed	Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein.	CDC14C CDC14B	2.46e-05	2	173	2	18547142
Pubmed	Genetic suppression of agrin reduces mania-like behavior in Na+ , K+ -ATPase α3 mutant mice.	ATP1A3 AGRN	2.46e-05	2	173	2	22520507
Pubmed	ATG14 and RB1CC1 play essential roles in maintaining muscle homeostasis.	ATG14 RB1CC1	2.46e-05	2	173	2	33794726
Pubmed	Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer.	EXO5 PLEC	2.46e-05	2	173	2	29761480
Pubmed	Alpha3Na+/K+-ATPase is a neuronal receptor for agrin.	ATP1A3 AGRN	2.46e-05	2	173	2	16630822
Pubmed	Cux2 expression regulated by Lhx2 in the upper layer neurons of the developing cortex.	CUX2 LHX2	2.46e-05	2	173	2	31708105
Pubmed	Diagnostic utility of LDH, CA125 and CYFRA21-1 in tuberculosis pleural effusion.	KRT19 MUC16	2.46e-05	2	173	2	33495032
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	MEAF6 ARID4B CALD1 ATRX RSL1D1 SEPTIN9 RRBP1 BPTF RBM19 ANKRD11 SAFB2 ZNF638 SMARCC1 SMARCC2 SYMPK HDLBP	2.47e-05	954	173	16	36373674
Pubmed	Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications.	NCKIPSD PPP1R11 SMARCC1 OXSR1 GPT2	2.50e-05	69	173	5	34941261
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	ATRX NCKIPSD RTN3 SPTBN4 TRAP1 SAFB2 SMARCC2 CDYL MPND FSCN1 AGRN KIF1C	2.63e-05	560	173	12	21653829
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NRCAM TCOF1 WDR7 SRGAP2 SPECC1L ARMCX4 SPTBN4 CELSR2 SAFB2 SMARCC1 SMARCC2 MACF1 FSCN1 GOLGA8A AGRN PCNT	2.76e-05	963	173	16	28671696
Pubmed	Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.	FANCA SMARCC1 SMARCC2	3.33e-05	13	173	3	11726552
Pubmed	Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse.	COL6A3 KIF1C HDLBP	3.33e-05	13	173	3	15905556
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RTEL1 ANKRD26 RNF213 ATG14 VARS2 BIRC6 SCAPER SAFB2 MACF1 FAM135A KIF1C	3.99e-05	493	173	11	15368895
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	TOE1 BPTF SCAF1 SAFB2 ZNF638 SMARCC1 PCNT SYMPK	3.99e-05	251	173	8	31076518
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	COL6A3 RNF213 TRAP1 PLEC DMD ZNHIT2 PCNT	4.46e-05	187	173	7	26460568
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MEAF6 ARID4B TCOF1 NOL12 TIMM23 RNF213 FAM83H BPTF SCAF1 PJA2 ZFHX4 SCAPER XRN1 SMARCC1 SMARCC2 MACF1 CDH16	4.56e-05	1116	173	17	31753913
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	AIMP1 ATG2B RB1CC1 BIRC6 RBM20 DENND4C ZFHX4 XRN1 PLEC PCNT	5.05e-05	418	173	10	34709266
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	PHACTR2 ANKRD26 SRGAP2 SLC39A10 GPRIN1 CELSR2 PALM MACF1 DMD FAM135A	5.35e-05	421	173	10	36976175
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SEPTIN9 ANKRD26 XRN1 ZNF638 MACF1 DNMBP FAM135A AHNAK2	5.55e-05	263	173	8	34702444
Pubmed	ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.	MEAF6 ARID4B SMARCC1 SMARCC2	5.71e-05	42	173	4	16387653
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	CYLC2 CALD1 TCOF1 ZGPAT MACF1 DMD USP15	6.20e-05	197	173	7	20811636
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	AIMP1 KRT19 RSL1D1 ATG2B RNF213 SPECC1L PLEC AHNAK2	6.33e-05	268	173	8	33024031
Pubmed	Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice.	WDR7 ZFHX4 GEN1	6.46e-05	16	173	3	16096065
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	SYN3 NRCAM WDR7 RTN3 GPRIN1 AMER2 PALM MACF1 PLEC	6.53e-05	347	173	9	17114649
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	WDR7 BIRC6 TMEM38B DENND4C FAM83H FANCA ALKBH1 USP5 FGD1 PALM MACF1 AGRN FAM135A	6.92e-05	719	173	13	35337019
Pubmed	Early-onset aging and defective DNA damage response in Cdc14b-deficient mice.	CDC14C CDC14B	7.36e-05	3	173	2	21262768
Pubmed	Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase.	ATP1A3 ATP1A4	7.36e-05	3	173	2	26373354
Pubmed	Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription.	CDC14C CDC14B	7.36e-05	3	173	2	22355704
Pubmed	BAF chromatin remodeling complex: cortical size regulation and beyond.	SMARCC1 SMARCC2	7.36e-05	3	173	2	23974113
Pubmed	Up-Regulation of Intestinal Phosphate Transporter NaPi-IIb (SLC34A2) by the Kinases SPAK and OSR1.	SLC34A2 OXSR1	7.36e-05	3	173	2	26506223
Pubmed	Structural and functional evaluation of branched myofibers lacking intermediate filaments.	KRT19 DMD	7.36e-05	3	173	2	22592402
Pubmed	Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19.	KRT19 DMD	7.36e-05	3	173	2	16000376
Pubmed	Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.	KRT19 MUC16	7.36e-05	3	173	2	26163610
Pubmed	Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice.	KRT19 MAP3K14	7.36e-05	3	173	2	36042192
Pubmed	Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance.	NRCAM KRT19	7.36e-05	3	173	2	18602664
Pubmed	The extracellular matrix protein agrin promotes heart regeneration in mice.	DMD AGRN	7.36e-05	3	173	2	28581497
Pubmed	CDC14B acts through FZR1 (CDH1) to prevent meiotic maturation of mouse oocytes.	CDC14C CDC14B	7.36e-05	3	173	2	19129509
Pubmed	Cdc14A and Cdc14B Redundantly Regulate DNA Double-Strand Break Repair.	CDC14C CDC14B	7.36e-05	3	173	2	26283732
Pubmed	Mass Spectrometric Analysis Identifies AIMP1 and LTA4H as FSCN1-Binding Proteins in Laryngeal Squamous Cell Carcinoma.	AIMP1 FSCN1	7.36e-05	3	173	2	31287215
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RNF213 PPP1R11 SLC39A10 RB1CC1 PPEF2 GPRIN1 BIRC6 CDC14B RBM20 C2CD3 ZNF638 PALM DMD PCNT SYMPK HDLBP	7.59e-05	1049	173	16	27880917
Pubmed	POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.	ARID4B MAP3K14 CMYA5 ALKBH1 MICALL2 SAFB2 PLEC PCNT	7.96e-05	277	173	8	30745168
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	NRCAM ATRX TCOF1 AIMP1 RB1CC1 DSCAML1 SCAF1 CELSR2 MACF1	8.28e-05	358	173	9	32460013
Pubmed	Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.	WDR7 RB1CC1 BIRC6 FANCA BPTF ZNF638 PALM CCDC144A HSPB7	8.45e-05	359	173	9	35559673
Pubmed	Architectural niche organization by LHX2 is linked to hair follicle stem cell function.	LHX2 MACF1 PCNT	9.34e-05	18	173	3	24012369
Pubmed	Generalist genes analysis of DNA markers associated with mathematical ability and disability reveals shared influence across ages and abilities.	FRAS1 NRCAM SRGAP2	9.34e-05	18	173	3	20602751
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	ARID4B RSL1D1 ATG2B ANKRD26 GON4L DENND4C C2CD3 XRN1 ZNF638 CDYL USP15 PCNT	1.01e-04	645	173	12	25281560
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CALD1 TCOF1 ATG2B SPECC1L GPRIN1 BPTF XRN1 SMARCC1 USP15 SYMPK HDLBP	1.04e-04	549	173	11	38280479
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	FRAS1 ATRX SREBF2 GON4L RRBP1 RBM20 FANCA LPIN3 XRN1 ZNF638 SMARCC1 AGRN	1.09e-04	650	173	12	38777146
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	FRAS1 CALD1 RSL1D1 RTN3 RRBP1 GPRIN1 TMEM38B CLMN HDLBP	1.18e-04	375	173	9	32788342
Pubmed	In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer.	SCAF1 USP15	1.47e-04	4	173	2	38902237
Pubmed	Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia.	ATP1A3 ATP1A4	1.47e-04	4	173	2	21849490
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	MYLK RNF213	1.47e-04	4	173	2	26147384
Interaction	KRT19 interactions	NUDT19 CCHCR1 KRT19 ANKRD26 RB1CC1 BIRC6 FAM83H ZNF638 PLEC DMD DNMBP AGRN PCNT KIF1C	1.47e-07	282	172	14	int:KRT19
Interaction	GOLGA1 interactions	ATG2B ANKRD26 BIRC6 DENND4C CLMN MACF1 DNMBP SYCE1 AHNAK2 PCNT	4.01e-06	183	172	10	int:GOLGA1
Interaction	MBD3 interactions	CCHCR1 ARID4B ATRX USP43 BIRC6 BPTF PHF20L1 SMARCC1 SMARCC2 SYCE1 PCNT SYMPK	9.12e-06	295	172	12	int:MBD3
Interaction	PPP1R12A interactions	MYLK CALD1 SEPTIN9 SPECC1L RB1CC1 RRBP1 CDC14B BPTF SMARCC1 SMARCC2 MACF1 USP15	2.18e-05	322	172	12	int:PPP1R12A
Interaction	YWHAH interactions	PHACTR2 KRT19 NCKIPSD USP43 ANKRD26 SRGAP2 SPECC1L RB1CC1 DENND4C FAM83H LPIN3 PJA2 C2CD3 CLMN XRN1 ANKRD11 ZNF638 MACF1 PLEC DNMBP GEN1 AHNAK2 PCNT KIF1C	2.27e-05	1102	172	24	int:YWHAH
Interaction	HDAC1 interactions	ARID4B ATRX ATG2B USP43 GON4L BCL3 RB1CC1 BIRC6 RBM20 DENND4C ZGPAT BPTF ZFHX4 PHF20L1 XRN1 ZNF638 SMARCC1 SMARCC2 CDYL PLEC FSCN1 USP15 PCNT SYMPK	2.48e-05	1108	172	24	int:HDAC1
Interaction	SNRNP40 interactions	BCL9L TCOF1 RSL1D1 GON4L PPWD1 RBM20 TOE1 ZGPAT SCAF1 PHF20L1 SMARCC1 SMARCC2 CDYL FSCN1 ZNHIT2 USP15 HDLBP	3.37e-05	637	172	17	int:SNRNP40
Interaction	CIT interactions	TCOF1 RSL1D1 SEPTIN9 NCKIPSD RNF213 SPECC1L CMYA5 PPWD1 BIRC6 TOE1 SPTBN4 BPTF SCAF1 TRAP1 CELSR2 RBM19 SAFB2 ZNF638 SMARCC1 SMARCC2 MACF1 CDYL OXSR1 PLEC FSCN1 AHNAK2 SYMPK HDLBP	3.93e-05	1450	172	28	int:CIT
Interaction	TOP3B interactions	NUDT19 FRAS1 RTEL1 AIMP1 SRGAP2 BIRC6 CDC14B FAM83H FANCA LPIN3 ZGPAT SCAF1 VAC14 C2CD3 CELSR2 RBM19 ZNF335 XRN1 ANKRD11 SAFB2 PALM PLEC DNMBP AGRN AHNAK2 PCNT SYMPK HDLBP	5.00e-05	1470	172	28	int:TOP3B
Interaction	PPP1CB interactions	MYLK CALD1 SEPTIN9 RNF213 PPP1R11 SPECC1L RB1CC1 RRBP1 USP5 MICALL2 SAFB2 ZNF638 PLEC HDLBP	5.23e-05	469	172	14	int:PPP1CB
Interaction	YWHAG interactions	BNIP5 PHACTR2 KRT19 NCKIPSD USP43 ANKRD26 RTN3 SRGAP2 SPECC1L RB1CC1 PPEF2 DENND4C FAM83H LPIN3 PJA2 C2CD3 CLMN ANKRD11 ZNF638 MACF1 DNMBP GEN1 AHNAK2 KIF1C PSD4	5.98e-05	1248	172	25	int:YWHAG
Interaction	ADARB1 interactions	TCOF1 RSL1D1 SEPTIN9 NOL12 RRBP1 BPTF SCAF1 RBM19 ZNF638 SMARCC1 SMARCC2 PLEC ATP1A4 HDLBP	8.17e-05	489	172	14	int:ADARB1
GeneFamily	Fibronectin type III domain containing	MYLK MYOM1 NRCAM TSPOAP1 CMYA5 DSCAML1 CNTN5 TNXB EPHA10	9.03e-07	160	116	9	555
GeneFamily	ATPase Na+/K+ transporting subunits	ATP1A3 ATP1A4	8.39e-04	7	116	2	1208
GeneFamily	EF-hand domain containing\|Plakins	MACF1 PLEC	1.11e-03	8	116	2	939
GeneFamily	Autophagy related	ATG2B ATG14 RB1CC1	1.22e-03	33	116	3	1022
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ATRX WDR7 SEPTIN9 MAP3K14 SRGAP2 SPECC1L RB1CC1 BPTF PJA2 C2CD3 ZNF638 MACF1 CDYL OXSR1 DMD DNMBP USP15 MN1 ZNF292 PCNT	1.05e-06	856	173	20	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	ATRX WDR7 SEPTIN9 SRGAP2 SPECC1L BPTF PJA2 C2CD3 ZNF638 CDYL OXSR1 DNMBP ZNF292	1.43e-05	466	173	13	M13522
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	CUX2 ARID4B SYN3 NRCAM ATRX TCOF1 RSL1D1 ANKRD26 RTN3 NR6A1 LHX2 VAC14 CELSR2 PLCH2 DMD ATP1A3 LONRF2 ZNHIT2 USP15 GEN1 ZNF292 PCNT	1.17e-05	989	168	22	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	NUDT19 ARID4B ATRX TCOF1 TSPOAP1 RSL1D1 RNF213 BCL3 CDC14B TOE1 FANCA SPTBN4 LHX2 SSC5D ZFHX4 PLCH2 SMARCC2 MACF1 CDYL ATP1A3 FAM135A ZNF292	1.17e-05	989	168	22	Facebase_RNAseq_e10.5_Maxillary Arch_1000
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID4B ATRX RNF213 BIRC6 BPTF XRN1 ANKRD11 MACF1 USP15 GOLGA8A ZNF292	4.08e-10	200	173	11	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	MYLK CALD1 ATRX RTN3 RB1CC1 BPTF PJA2 ANKRD11 AHNAK2	8.96e-08	199	173	9	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D DMD ASB2 ATP1A4 LONRF2 TNXB	9.35e-08	200	173	9	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 CMYA5 SSC5D ZFHX4 DMD ATP1A4 TNXB	9.35e-08	200	173	9	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D ZFHX4 DMD ASB2 ATP1A4 TNXB	9.35e-08	200	173	9	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYLK CALD1 NRCAM SSC5D MACF1 DMD TNXB	4.37e-07	175	173	8	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX CMYA5 RBM20 XRN1 ZNF638 MACF1 DMD HDLBP	4.56e-07	176	173	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 NRCAM DSCAML1 ZFHX4 SCN9A DMD ATP1A4 EPHA10	6.39e-07	184	173	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX RRBP1 BIRC6 XRN1 ANKRD11 ZNF638 SMARCC1 MACF1	6.39e-07	184	173	8	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 NRCAM DSCAML1 ZFHX4 SCN9A DMD ATP1A4 EPHA10	6.39e-07	184	173	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 NRCAM DSCAML1 ZFHX4 SCN9A DMD ATP1A4 EPHA10	6.39e-07	184	173	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 MYLK CALD1 ATRX RRBP1 BPTF ANKRD11 MACF1	8.13e-07	190	173	8	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK NRCAM RRBP1 LHX2 MICALL2 MACF1 TNXB	1.07e-06	197	173	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FRAS1 ARID4B RNF213 XRN1 ANKRD11 MACF1 GOLGA8A ZNF292	1.07e-06	197	173	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	ATRX ANKRD26 RRBP1 SCAPER SAFB2 ZNF638 GOLGA8A ZNF292	1.07e-06	197	173	8	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	PHACTR2 ATRX IDO1 ANKRD26 RB1CC1 BPTF ANKRD11 HDLBP	1.11e-06	198	173	8	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ATRX RNF213 BPTF ANKRD11 MACF1 USP15 GOLGA8A ZNF292	1.15e-06	199	173	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D DMD ASB2 ATP1A4 TNXB	1.15e-06	199	173	8	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	PHACTR2 ARID4B ATRX IDO1 RB1CC1 BPTF ANKRD11 ZNF292	1.15e-06	199	173	8	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 CMYA5 SSC5D ZFHX4 DMD TNXB	1.15e-06	199	173	8	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK CALD1 MYOM1 RBM20 CLMN DMD ASB2 HSPB7	1.15e-06	199	173	8	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ATRX RNF213 BIRC6 BPTF MACF1 FSCN1 FAM135A PCNT	1.20e-06	200	173	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D DMD ASB2 ATP1A4 TNXB	1.20e-06	200	173	8	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D DMD ASB2 ATP1A4 LONRF2	1.20e-06	200	173	8	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D231\|Adult / Lineage, Cell type, age group and donor	MYLK CALD1 MYOM1 NRCAM SSC5D ASB2 MN1	3.13e-06	160	173	7	d783d29150033e9181c0e30870070268fed3fd85
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FOXN2 NCKIPSD SREBF2 ANKRD26 C1RL FGD1 CDYL	3.84e-06	165	173	7	94a5211072464fc24592bb107a853ce832e816fe
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CUX2 MYLK USP43 CLMN PLCH2 CNTN5 ASB2	4.67e-06	170	173	7	3174ea9cf93892a8b41de10fd4ff6f06bb41502d
ToppCell	356C-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MYOM1 IDO1 MAP3K14 DSCAML1 DMD ASB2 CNR2	4.85e-06	171	173	7	3d60e7ecf25e4b781ba2387671b2aad247fb75ff
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK CALD1 MYOM1 RBM20 DMD ASB2 HSPB7	5.24e-06	173	173	7	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP4V2 COL6A3 MYLK CALD1 PCDHA10 SSC5D TNXB	7.05e-06	181	173	7	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYLK MYOM1 NRCAM DMD ASB2 MN1 HSPB7	7.57e-06	183	173	7	a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 MYLK CALD1 SSC5D ZFHX4 DMD TNXB	7.57e-06	183	173	7	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYOM1 CMYA5 RBM20 TRIM55 DMD ASB2 HSPB7	7.84e-06	184	173	7	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	COL6A3 FRAS1 MYLK CALD1 SYN3 MACF1 TNXB	8.72e-06	187	173	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CUX2 NR6A1 DSCAML1 CLMN ZNF638 DMD GPT2	8.72e-06	187	173	7	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF831 SPTBN4 CELSR2 PLCH2 ATP1A3 GOLGA8A EPHA10	8.72e-06	187	173	7	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF831 SPTBN4 CELSR2 PLCH2 ATP1A3 GOLGA8A EPHA10	8.72e-06	187	173	7	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	COL6A3 MYLK CALD1 NRCAM SSC5D DMD TNXB	8.72e-06	187	173	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF831 SPTBN4 CELSR2 PLCH2 ATP1A3 GOLGA8A EPHA10	8.72e-06	187	173	7	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 MYLK CALD1 SSC5D DMD ASB2 LONRF2	9.02e-06	188	173	7	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 MYLK CALD1 SSC5D DMD ASB2 HSPB7	9.02e-06	188	173	7	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	COPD-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	CALD1 TMEM38B RBM20 CLMN DMD ASB2 HSPB7	9.02e-06	188	173	7	9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KRT19 SEPTIN9 SREBF2 NR6A1 CLMN LONRF2 FAM135A	9.02e-06	188	173	7	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYLK CALD1 MYOM1 TMEM38B DMD ASB2 HSPB7	9.02e-06	188	173	7	a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 CALD1 CDH23 ZFHX4 LONRF2 MN1 TNXB	1.00e-05	191	173	7	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 FRAS1 MYLK CALD1 SYN3 MACF1 TNXB	1.00e-05	191	173	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	FRAS1 ARID4B RB1CC1 RRBP1 BPTF ZNF638 ZNF292	1.03e-05	192	173	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	TCOF1 FANCA BPTF ANKRD11 GOLGA8A AHNAK2 ZNF292	1.03e-05	192	173	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 FRAS1 MYLK CALD1 SYN3 MACF1 TNXB	1.03e-05	192	173	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	IPF-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	MYOM1 TMEM38B RBM20 CLMN DMD ASB2 HSPB7	1.03e-05	192	173	7	9b06c7336624ef21f8e5393725b56038a8028e57
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CUX2 PHACTR2 MYLK SYN3 CMYA5 CLMN SCN9A	1.03e-05	192	173	7	25460ca9ebd3d49f666394cf99ab77a5e8f77250
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK CALD1 MYOM1 TMEM38B ASB2 MN1 HSPB7	1.07e-05	193	173	7	18e11d515147accef9aee26e934b358b445e18e2
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 MYLK CALD1 SYN3 CDH23 MACF1 TNXB	1.07e-05	193	173	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK CALD1 MYOM1 TMEM38B ASB2 MN1 HSPB7	1.07e-05	193	173	7	7766f495f2f945802ef9a5b994cd00bb64d0dfe3
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	FRAS1 ARID4B RB1CC1 RRBP1 BPTF ZNF638 ZNF292	1.07e-05	193	173	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK CALD1 MYOM1 TMEM38B ASB2 MN1 HSPB7	1.07e-05	193	173	7	ce3e8cf30b7b4d5c7a8f3d64c21d81d2c3cab5c1
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYLK CALD1 NRCAM SSC5D TNXB HSPB7	1.11e-05	194	173	7	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARID4B ATRX RB1CC1 RRBP1 ANKRD11 MACF1 FSCN1	1.11e-05	194	173	7	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IDO1 TCOF1 MAP3K14 SSC5D CELSR2 ASB2 FAM135A	1.11e-05	194	173	7	5a048bd2af30975fdc57ff40bc49aa5811c830d8
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	FRAS1 CALD1 MYOM1 CMYA5 RBM20 TRIM55 DMD	1.11e-05	194	173	7	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	FRAS1 CALD1 MYOM1 CMYA5 RBM20 TRIM55 DMD	1.11e-05	194	173	7	c3535f7cc0076653c72db582047cff053c322397
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 MYLK CALD1 NRCAM SSC5D TNXB HSPB7	1.11e-05	194	173	7	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical\|TCGA-Thryoid / Sample_Type by Project: Shred V9	NRCAM KRT19 SEPTIN9 SLC34A2 SYTL5 PALM AGRN	1.11e-05	194	173	7	b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d
ToppCell	3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-\|blood / Manually curated celltypes from each tissue	ARID4B BCL3 RRBP1 ANKRD11 GOLGA8A MVD CNR2	1.14e-05	195	173	7	1470f562ebcfe7da367964ecfd6c7f43bcdb4a73
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 MYLK CALD1 MYOM1 CNTN5 DMD ASB2	1.18e-05	196	173	7	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	CUX2 ARID4B CALD1 ATRX CELSR2 ZFHX4 ZNF292	1.18e-05	196	173	7	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	FRAS1 CALD1 KRT19 CMYA5 CELSR2 PLCH2 GOLGA8A	1.18e-05	196	173	7	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	CUX2 ARID4B CALD1 ATRX CELSR2 ZFHX4 ZNF292	1.18e-05	196	173	7	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 MYLK CALD1 MYOM1 CNTN5 DMD ASB2	1.18e-05	196	173	7	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYLK CALD1 MYOM1 TMEM38B CLMN DMD HSPB7	1.18e-05	196	173	7	1d94cecd378a829dd8014fc086d7fca48c953a91
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYLK CALD1 MYOM1 TMEM38B CLMN DMD HSPB7	1.18e-05	196	173	7	aacec48285bcb7ccf1b538187071885e3602cc49
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK CALD1 MYOM1 RBM20 DMD ASB2 HSPB7	1.22e-05	197	173	7	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	Basal_cells\|World / lung cells shred on cell class, cell subclass, sample id	FRAS1 CALD1 KRT19 CMYA5 CELSR2 PLCH2 GOLGA8A	1.22e-05	197	173	7	24360b660000bdfb999d58fbf4e29585a97e1785
ToppCell	Transverse-B_cell-B_cell_IgG_Plasma\|B_cell / Region, Cell class and subclass	BNIP5 COL6A3 MUC16 BCL3 FAM186B FAM83H PIK3R5	1.22e-05	197	173	7	a0a096e8e80763a92d5d7396eb678a4587771a3a
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	ARID4B RNF213 BCL3 XRN1 ANKRD11 USP15 ZNF292	1.22e-05	197	173	7	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK CALD1 MYOM1 NRCAM CDH23 ASB2 MN1	1.22e-05	197	173	7	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARID4B RNF213 BCL3 XRN1 ANKRD11 USP15 ZNF292	1.26e-05	198	173	7	44417089b62056269cac38d3134ff209c05b7007
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IDO1 TCOF1 CDH23 VAC14 ASB2 GPT2 PIK3R5	1.26e-05	198	173	7	fa5c15a656d4132950092919600e270f1fd79abf
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARID4B RNF213 BCL3 XRN1 ANKRD11 USP15 ZNF292	1.26e-05	198	173	7	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	CALD1 ATRX ANKRD26 RB1CC1 BPTF ANKRD11 ZNF292	1.31e-05	199	173	7	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	ARID4B ATRX ANKRD26 RB1CC1 BPTF ANKRD11 ZNF292	1.31e-05	199	173	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	PHACTR2 ATRX IDO1 RB1CC1 BPTF ANKRD11 ZNF292	1.31e-05	199	173	7	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D ZFHX4 DMD TNXB	1.31e-05	199	173	7	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	CALD1 ATRX ANKRD26 RB1CC1 BPTF ANKRD11 ZNF292	1.31e-05	199	173	7	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK NRCAM SPECC1L MICALL2 MACF1 TNXB	1.35e-05	200	173	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK CALD1 SSC5D DMD ASB2 ATP1A4 LONRF2	1.35e-05	200	173	7	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYLK CALD1 MYOM1 DMD ASB2 ATP1A4 HSPB7	1.35e-05	200	173	7	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Club\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	KRT19 MUC16 RRBP1 CMYA5 SYTL5 GPT2 MVD	1.35e-05	200	173	7	292c63693eb7f435335a8cfba07aa35b72139393
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK CALD1 MYOM1 RBM20 DMD ASB2 HSPB7	1.35e-05	200	173	7	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D ZFHX4 DMD TNXB	1.35e-05	200	173	7	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D DMD ASB2 ATP1A4	1.35e-05	200	173	7	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D DMD ASB2 ATP1A4	1.35e-05	200	173	7	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D DMD ASB2 ATP1A4	1.35e-05	200	173	7	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D ZFHX4 DMD TNXB	1.35e-05	200	173	7	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK CALD1 SSC5D DMD ASB2 TNXB	1.35e-05	200	173	7	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYLK CALD1 SSC5D DMD ASB2 ATP1A4 LONRF2	1.35e-05	200	173	7	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ARID4B RNF213 BPTF XRN1 ANKRD11 MACF1 USP15	1.35e-05	200	173	7	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	tumor_Lung-Epithelial_cells-tS2\|Epithelial_cells / Location, Cell class and cell subclass	KRT19 SEPTIN9 MUC16 RNF213 PLEC FSCN1 AGRN	1.35e-05	200	173	7	caa2645d4d96f76e8c9800fe45afbfac8bd34bd9
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 MYLK NRCAM SPECC1L MICALL2 MACF1 TNXB	1.35e-05	200	173	7	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYOM1 MAP3K14 MUC16 ATG14 FSCN1 CCDC144A	2.68e-05	150	173	6	7a381f5ae94eba5eb60dcbf83416b4eb18c279ea
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ATRX BPTF ANKRD11 MACF1 ZNF292	9.11e-05	49	101	5	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Drug	Denatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A	NRCAM SEPTIN9 ANKRD26 GON4L SPATA2 CELSR2 PLEC FSCN1 AGRN SYMPK	2.01e-06	191	172	10	3123_DN
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ARID4B NOL12 SREBF2 RRBP1 SCAPER SAFB2 PLEC FSCN1 MVD ZNF292	2.21e-06	193	172	10	4846_DN
Drug	Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A	ZNF787 FOXN2 RTEL1 NOL12 RRBP1 ZGPAT ZNF335 SAFB2 PLEC KIF1C	2.91e-06	199	172	10	2756_DN
Drug	Ethamivan [304-84-7]; Down 200; 18uM; PC3; HT_HG-U133A	MYLK MAP3K14 RB1CC1 SPATA2 USP5 MICALL2 SMARCC1 SMARCC2 AGRN	1.75e-05	194	172	9	7260_DN
Drug	Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	RTEL1 ANKRD26 GON4L SLC34A2 VAC14 ZFHX4 RBM19 FGD1 FSCN1	1.90e-05	196	172	9	4974_UP
Drug	Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A	FOXN2 CALD1 RTEL1 RRBP1 ZFHX4 RBM19 SMARCC2 MVD ZNF292	1.97e-05	197	172	9	6796_UP
Drug	chlorpropamide; Up 200; 100uM; MCF7; HG-U133A	ZNF787 MYLK RTEL1 SREBF2 NR6A1 RRBP1 PHF20L1 SMARCC2 PLEC	1.97e-05	197	172	9	141_UP
Drug	Nimodipine [66085-59-4]; Up 200; 9.6uM; PC3; HT_HG-U133A	PHACTR2 CALD1 NOL12 SLC34A2 GRM6 CDC14B RBM19 SCAPER PALM	2.06e-05	198	172	9	6320_UP
Drug	rotenone; Down 200; 1uM; MCF7; HT_HG-U133A	ANKRD26 GON4L SLC34A2 NR6A1 LHX2 FGD1 PALM FSCN1 SYMPK	2.06e-05	198	172	9	5915_DN
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; HL60; HG-U133A	NOL12 SREBF2 PPWD1 TMEM38B PHF20L1 ANKRD11 MTRR CDYL PSD4	2.14e-05	199	172	9	1738_DN
Disease	nervous system disease (implicated_via_orthology)	ATP1A3 ATP1A4 KIF1C	3.91e-05	12	169	3	DOID:863 (implicated_via_orthology)
Disease	Intellectual Disability	CUX2 GON4L SPECC1L BPTF ZNF335 SCAPER SMARCC2 MACF1 GPT2 MN1 ZNF292	5.78e-05	447	169	11	C3714756
Disease	Macrostomia	FRAS1 SPECC1L	1.94e-04	4	169	2	C0024433
Disease	serum gamma-glutamyl transferase measurement	FOXN2 CUX2 CALD1 ATRX SEPTIN9 GON4L SPECC1L PGM1 BPTF LRGUK CELSR2 DNMBP HSPB7 ZNF292 HDLBP	2.61e-04	914	169	15	EFO_0004532
Disease	eosinophil count	CUX2 MAP3K14 NCKIPSD ATG14 BCL3 RRBP1 SPATA2 BPTF XRN1 ANKRD11 PLEC ASB2 USP15 TNXB PIK3R5 EPHA10 CNR2 ZNF292 SYMPK HDLBP	3.52e-04	1488	169	20	EFO_0004842
Disease	asthma	COL6A3 ARID4B RTEL1 MAP3K14 MUC16 SRGAP2 BCL3 LHX2 TRAP1 ANKRD11 MPND PCNT SYMPK	4.11e-04	751	169	13	MONDO_0004979
Disease	myeloperoxidase measurement	TSPOAP1 RRBP1 TNXB	4.36e-04	26	169	3	EFO_0005243
Disease	meningioma (is_implicated_in)	MTRR MN1	4.82e-04	6	169	2	DOID:3565 (is_implicated_in)
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP1A3 ATP1A4	6.72e-04	7	169	2	DOID:0060178 (implicated_via_orthology)
Disease	Ovarian Mucinous Adenocarcinoma	MYLK MAP3K14 RPS6KC1	7.37e-04	31	169	3	C1335167
Disease	coffee consumption	CUX2 NRCAM FANCA	8.10e-04	32	169	3	EFO_0004330
Disease	alcohol use disorder (implicated_via_orthology)	SREBF2 SMARCC1 SMARCC2 ATP1A3 ATP1A4 PSD4	9.36e-04	195	169	6	DOID:1574 (implicated_via_orthology)
Disease	Abnormality of the face	MN1 ZNF292	1.14e-03	9	169	2	C4025871
Disease	pyoderma gangrenosum	SYN3 USP15	1.14e-03	9	169	2	EFO_0006835
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCC1 SMARCC2	1.14e-03	9	169	2	DOID:0050340 (implicated_via_orthology)
Disease	Coffin-Siris syndrome (implicated_via_orthology)	SMARCC1 SMARCC2	1.14e-03	9	169	2	DOID:1925 (implicated_via_orthology)
Disease	adseverin measurement	C1RL DNMBP	1.42e-03	10	169	2	EFO_0801358
Disease	skin microbiome measurement	PHACTR2 SRGAP2 LHX2	1.45e-03	39	169	3	EFO_0801228
Disease	complement C1q tumor necrosis factor-related protein 1 measurement	CDH23 CELSR2	2.07e-03	12	169	2	EFO_0801493
Disease	granulins measurement	CDH23 CELSR2	2.07e-03	12	169	2	EFO_0008141
Disease	epilepsy (implicated_via_orthology)	NRCAM SCN9A CDYL ATP1A3 ATP1A4	2.53e-03	163	169	5	DOID:1826 (implicated_via_orthology)
Disease	Hypermetropia	SEPTIN9 DSCAML1 ANKRD11 AGRN	2.96e-03	103	169	4	HP_0000540
Disease	Leukemia, Myelocytic, Acute	SEPTIN9 FANCA MN1 AGRN CNR2	3.27e-03	173	169	5	C0023467
Disease	Malignant neoplasm of breast	NRCAM IDO1 LRRC37A2 SREBF2 MAGEE1 RB1CC1 GRM6 HOXD11 MACF1 DMD ZNHIT2 GEN1 CNR2 HDLBP	3.64e-03	1074	169	14	C0006142
Disease	preeclampsia, parental genotype effect measurement	CCHCR1 ZNF831	3.71e-03	16	169	2	EFO_0000668, EFO_0005939
Disease	lipoprotein A measurement	BCL3 DSCAML1 ZGPAT CELSR2	3.99e-03	112	169	4	EFO_0006925
Disease	Dystonia, Limb	COL6A3 ATP1A3	4.19e-03	17	169	2	C0751093
Disease	Dystonia, Diurnal	COL6A3 ATP1A3	4.19e-03	17	169	2	C0393610
Disease	Moyamoya Disease	RNF213 PCNT	4.19e-03	17	169	2	C0026654
Disease	Neoplasm Invasiveness	MYLK KRT19 SEPTIN9 SLC39A10 DMD	4.24e-03	184	169	5	C0027626
Disease	severe acute respiratory syndrome, COVID-19	COL6A3 TRPC7 SEPTIN9 SRGAP2 PALM DMD GOLGA8A CNR2	4.38e-03	447	169	8	EFO_0000694, MONDO_0100096
Disease	Dystonia, Paroxysmal	COL6A3 ATP1A3	4.70e-03	18	169	2	C0393588
Disease	Feeding difficulties	MN1 ZNF292	4.70e-03	18	169	2	C0232466
Disease	X-11470 measurement	VARS2 TNXB	5.23e-03	19	169	2	EFO_0021241
Disease	skin sensitivity to sun	FANCA ANKRD11	5.23e-03	19	169	2	EFO_0004795
Disease	peripheral neuropathy, response to docetaxel trihydrate	TRPC7 VAC14	5.23e-03	19	169	2	EFO_0003100, GO_1902519
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	NRCAM BCL3 BIRC6 BPTF CELSR2 MACF1	5.28e-03	276	169	6	EFO_0004612, EFO_0020943

Protein segments in the cluster

Peptide	Gene	Start	Entry
PALASAATKERTESE	BARGIN	531	Q6ZT62
SAAAEASAVLKVRPE	GPT2	26	Q8TD30
TVEVNDRKAEFPSSG	ARID4B	1001	Q4LE39
AEDASRTGAVPVKTV	AMER2	316	Q8N7J2
DSPAVAAAPERKTSV	ACTL7B	366	Q9Y614
KTPDEAARLVEGTSA	ANKRD30B	301	Q9BXX2
DVKDGVDAVPAAIST	ANKRD11	2036	Q6UB99
RTIPDKIGSTSGAEA	BIRC6	3941	Q9NR09
VKTGVRDPADVSSES	ATG14	211	Q6ZNE5
VATLATEPGEDAFRK	ALKBH1	11	Q13686
ADGSTPTDAIVKEFL	CDC14B	286	O60729
PETTKEGLRAISDVS	APOF	271	Q13790
EQSLADKTRGPTTAE	ASB2	36	Q96Q27
IAGSADSKPIDVSRL	AIMP1	141	Q12904
DPKSELFGETARSIE	AGRN	1156	O00468
VDPTSGELDVKRAFA	AKTIP	151	Q9H8T0
VKRDISAQEGASPAS	SPECC1L	951	Q69YQ0
PTRTVEVDSKAAEIG	CYLC2	101	Q14093
SGDSADVARDVKQPT	DNMBP	1446	Q6XZF7
TEAGAVPSRKSPADV	EDN2	116	P20800
LDNSTRGTDVKDIPF	CCDC144CP	271	Q8IYA2
APVLRVTASDRDKGS	CELSR2	416	Q9HCU4
VADVFGSKDTESLEP	FAM186B	401	Q8IYM0
TPTTSGEDVRDFAKV	DMD	3361	P11532
SSLSEIDEDEGRPTK	ANKRD26	651	Q9UPS8
RTPETGSDDAIKSIL	CUX2	641	O14529
EEKVSDLASRGQEPS	BPTF	1316	Q12830
ADGSTPTDAIVKRFL	CDC14C	256	A4D256
TLTVVADDGGPKVDS	CDH23	1386	Q9H251
SGPRAEVETKATAIA	ARMCX4	81	Q5H9R4
AKTQSEARPGATVDA	ARMCX4	246	Q5H9R4
AVKSDSDGEQTEPRF	ATG2B	1321	Q96BY7
EAPRSSVTETEADGK	CNR2	331	P34972
AEGEPSAAPTDVKAT	CNTN5	871	O94779
PTSGALDRVASATKI	PGM1	336	P36871
DSSATPVLQERDSKG	RBM19	246	Q9Y4C8
AERKPAESETGLSLE	RBM20	1006	Q5T481
ESDVSSAPDKEAGRE	NPFFR2	16	Q9Y5X5
GDRSEEEASSTEKPT	NOL12	131	Q9UGY1
EVLERGDSAPATAKE	PALM	96	O75781
AKEPLSRATETGEAR	TSPOAP1	1571	O95153
ESEEGKAAISQLRSP	OXSR1	346	O95747
LAPEKAAVLDTGASI	EXO5	106	Q9H790
SPDTADAESGKEIRE	RB1CC1	266	Q8TDY2
LRPEKDSSATAVDAI	MUC16	12131	Q8WXI7
AGELTSPKSDSELEV	LPIN3	216	Q9BQK8
ESNPSVREFVLSKGD	IDO1	311	P14902
EVDSAPGTDLAKILS	KRT19	236	P08727
SVENTAEEKRLGSPA	LRRC37A3	1196	O60309
VSKTLGDRFSAPAVE	MYLK	136	Q15746
PIERKGDASSIVSAI	FRAS1	2691	Q86XX4
PRVTKASVDSDSEGP	MAGEE1	436	Q9HCI5
SVENAAEEKRLGSPA	LRRC37A2	1196	A6NM11
KTDNTGTLPEDVAFR	NUDT19	111	A8MXV4
DDPSRKIDGDTIIFS	NRCAM	406	Q92823
SRGSDDSVPVISFKD	RPS6KC1	661	Q96S38
EEPTSLFQRDSETKG	RPS6KC1	856	Q96S38
KVSFSRDAPVGEEEA	MTRR	606	Q9UBK8
VNGLPEKDRETDTSA	LAIR1	226	Q6GTX8
AGVKRASEDSEEEPS	MICALL2	116	Q8IY33
ESSVAGLSSPELKVR	FAM135A	446	Q9P2D6
STTKEAARVAPATGE	PNMA6F	476	A0A0J9YX94
KTEEGSVRGALPAVS	KIF1C	391	O43896
RTAAVPTVKDALDAA	MACF1	836	O94854
ADGKDSIARQVAPES	MVD	176	P53602
APAISSAIDRGDTET	LHX2	26	P50458
GASDSETEETRKALP	LRGUK	771	Q96M69
IKDVRTFPDGSSVVD	LONRF2	596	Q1L5Z9
ISSPEDISDSKREFG	ANKS4B	281	Q8N8V4
SGTSDLKGEPAETRV	PHACTR2	286	O75167
GSRPRKIDTIAADES	EPHA10	146	Q5JZY3
DVLAGVSAEDKSRRP	MPND	196	Q8N594
RKGSAVDASVQEESP	PCNT	41	O95613
GKLATATSLPEDTVR	PAX4	201	O43316
KASSRASVGVAPEVA	PCDHA10	676	Q9Y5I2
KPRAFGESSTESDEE	PPP1R11	66	O60927
DVDPTSVTSALREDG	HSPB7	131	Q9UBY9
SSSDGTEKLPEREEI	ATRX	1011	P46100
TSTVAAPPKGEDAEA	GRM6	861	O15303
SEEAKRGAADVSSPE	BNIP5	306	P0C671
PAATTDQDKSEATRG	C2CD3	2301	Q4AC94
GVLKASAETVDPASL	FSCN1	476	Q16658
RTAVDGFQSESPEKL	CDYL	206	Q9Y232
GDDKATIPVTDAEFS	DSCAML1	1676	Q8TD84
SAAEEKPEDAALGVR	FANCA	626	O15360
EKGEREASSSVAAIP	CMYA5	1136	Q8N3K9
VSPERAGDTETLKDI	COL6A3	221	P12111
EAGAEKSSSAVAPQR	HOXD11	251	P31277
ESDVESTASSPRGAK	GON4L	391	Q3T8J9
EAGTPSLDSEAKEVA	BCL9L	126	Q86UU0
ESSTDIKAPEGFAVR	C1RL	66	Q9NZP8
LDNSTRGTDVKDIPF	CCDC144B	321	Q3MJ40
SAVEPSDEIKRASGD	DENND4C	1601	Q5VZ89
AAAVPTRESIKGSLS	CCHCR1	731	Q8TD31
DVFGKSDRPATVEDL	CYP4V2	361	Q6ZWL3
PVLKRDVAGDASESA	ATP1A3	431	P13637
IEKREPGSGTESDTS	MEAF6	111	Q9HAF1
AVDAARPKATLVDSE	FOXN2	36	P32314
KSEVESELSAIPDGF	GEN1	611	Q17RS7
SESTRVLESPDGKSE	FAM186A	651	A6NE01
LDNSTRGTDVKDIPF	CCDC144A	321	A2RUR9
PGGEAVRSAASTKVA	FAM83H	721	Q6ZRV2
VETVPATKEDSRFLG	GPRIN1	361	Q7Z2K8
ADIDAVDIKSGRSPL	BCL3	266	P20749
ESTAPAEALKDGEER	SCAPER	851	Q9BY12
LKPLAGTDDSVVSED	SLC39A10	561	Q9ULF5
PGTEVTRLSAEDADA	CDH16	351	O75309
SEADSEAGELRKPTQ	PPEF2	421	O14830
TAKEGSEAGPAAISI	MAP3K14	66	Q99558
DLSRGSEVTAPVASD	PHF20L1	476	A8MW92
TDDVGDAKARASVPT	MN1	1286	Q10571
AELDPGTISVSDDRA	NR6A1	41	Q15406
TSAEKEPEAAVPASG	GOLGA8A	426	A7E2F4
PSVRGEDAVSEAKSP	RTEL1	766	Q9NZ71
PEDLIAAFTETRDKG	RTN3	651	O95197
DSEDTVSIRSKSVPG	SYTL5	336	Q8TDW5
ATLEAEIAGESKSPA	VARS2	56	Q5ST30
TSQRGTPSEDEAKAE	SYN3	551	O14994
KDLEVLAEIASSPAG	VAC14	461	Q08AM6
RGEVASKPSELVSGS	RPGRIP1	186	Q96KN7
EEAPAGTRSQVKASE	TCOF1	281	Q13428
AEVEAGKDASSRDPV	NKX1-2	51	Q9UD57
ATQAEGPKRVSDSAI	PPWD1	481	Q96BP3
EKVPNRDSGIDSISS	FGD1	276	P98174
EEVKSEGTARPAETG	PSD4	516	Q8NDX1
PEVIIDKATSDDSGT	SCN9A	646	Q15858
DSSGPALKRSFEVEE	SEPTIN9	21	Q9UHD8
DPTSREDLAKGTTTA	SSC5D	886	A1L4H1
VDPRVASAAAKAALE	SMARCC1	706	Q92922
ASVVDPRVASAAAKS	SMARCC2	681	Q8TAQ2
GTTEEKAAAEAAVPR	NCKIPSD	296	Q9NZQ3
KAAAEAAVPRTIGAE	NCKIPSD	301	Q9NZQ3
SDTAPRERLIDAKTG	ARNTL	211	O00327
SAPGKSIEASVDVSA	AHNAK2	1176	Q8IVF2
SAPGKSIEASVDVSA	AHNAK2	1506	Q8IVF2
SAPGKSIEASVDVSE	AHNAK2	1671	Q8IVF2
SAPGKSIEASVDVSA	AHNAK2	1836	Q8IVF2
SAPGKSIEASVDVSA	AHNAK2	2496	Q8IVF2
VDVSAPKVEADGSLS	AHNAK2	2506	Q8IVF2
SAPGKSIEASVDVSE	AHNAK2	2826	Q8IVF2
RASVDTKEAEGAPQV	CALD1	516	Q05682
EILPIAKRATTGDAS	ATP1A4	446	Q13733
IPESSSDKVAGDIFL	CLMN	481	Q96JQ2
SREAQGEVPASDSKT	SLC34A2	671	O95436
VKDGDFLVRESATSP	SHC4	541	Q6S5L8
SRGSPNETELIESAK	RNF213	2901	Q63HN8
SLSLRKEPVATDVGD	SPATA2	271	Q9UM82
SEKSERDTPAAVTAE	ZFHX4	1256	Q86UP3
TAGEDEKSASPRSNV	USP43	856	Q70EL4
ERAAVSGKETSAPAA	TRIM55	491	Q9BYV6
KLRTAGPLESSETEE	RRBP1	1331	Q9P2E9
LSGDEDPKASTLRVV	PIK3R5	506	Q8WYR1
LSKDDVAPESGDTTV	RSL1D1	316	O76021
KSADDRGAEEPISVS	SOGA3	896	Q5TF21
IREGVSSTTPAKDAA	SCAF1	841	Q9H7N4
LTSKAEPTAGAVDRA	SYCE1	6	Q8N0S2
TRDTGSKGVADDVVP	PLCH2	951	O75038
DTEDGVVERSSPKSE	SRGAP2	786	O75044
RATPATEAGFEDEAK	SREBF2	646	Q12772
PVSVEAKTVARGDAS	TNXB	1656	P22105
EPASAAELSSVRKEE	ZNF292	2551	O60281
GVGSLASKPVDVASD	TMEM38B	266	Q9NVV0
IEKGETLPTEARFDS	XRN1	116	Q8IZH2
RETKGASAATGIPLE	USP15	946	Q9Y4E8
IASQIGAADKPRDVS	SPTBN4	1961	Q9H254
GAADKPRDVSSVEVL	SPTBN4	1966	Q9H254
AQDTSSVGPDRKLAE	SAFB2	241	Q14151
SEARDVFEKATVSAP	PLEC	3036	Q15149
PSVLFGADKDTEVAA	SYMPK	766	Q92797
ATPGRGEVESDKSVA	TOPAZ1	56	Q8N9V7
VKDASAAEPAAAERV	ZNHIT2	166	Q9UHR6
GRLFSTQTAEDKEEP	TRAP1	56	Q12931
STGARVIFPAAEDKD	HDLBP	756	Q00341
GDALVPAEDTDAKRT	ZNF831	576	Q5JPB2
AVVKSEDVEAGLASP	ZNF335	816	Q9H4Z2
PASDSFRSDVGKAVE	WDR7	291	Q9Y4E6
VDGLTDASSAFKVPR	ZP3	241	P21754
EELDSVPLVKSSAGD	PJA2	231	O43164
SETVPKAEAGPESAA	ZGPAT	101	Q8N5A5
DTDEFILPTGANKTR	TIMM23	56	O14925
GIKAARPEIADRATS	TOE1	406	Q96GM8
TFKGRGTPSIEDAES	TKTL1	216	P51854
EGRSAADSISESVPV	USP5	776	P45974
SSGKSVASDVPEELD	ZNF638	1906	Q14966
ASDRFEGVKTLPNET	TRPC7	406	Q9HCX4
SVRRAKGPEEAVAAD	ZNF787	216	Q6DD87
VSTEDSPRLEVESKG	MYOM1	1176	P52179